pharmacology of adrenergic neuron blockers
DESCRIPTION
ANS pharmacologyTRANSCRIPT
![Page 1: Pharmacology of adrenergic neuron blockers](https://reader036.vdocument.in/reader036/viewer/2022082511/546a71d8af79596c268b4a39/html5/thumbnails/1.jpg)
PHARMACOLOGY OF ADRENERGIC
NEURON BLOCKERS
Presentation by
Shahan ullah
Assigned by
Dr. Niaz Ali
![Page 2: Pharmacology of adrenergic neuron blockers](https://reader036.vdocument.in/reader036/viewer/2022082511/546a71d8af79596c268b4a39/html5/thumbnails/2.jpg)
ADRENERGIC NEURON BLOCKERS Reserpine Guanethidine Bretylium
![Page 3: Pharmacology of adrenergic neuron blockers](https://reader036.vdocument.in/reader036/viewer/2022082511/546a71d8af79596c268b4a39/html5/thumbnails/3.jpg)
MECHANISM
![Page 4: Pharmacology of adrenergic neuron blockers](https://reader036.vdocument.in/reader036/viewer/2022082511/546a71d8af79596c268b4a39/html5/thumbnails/4.jpg)
MECHANISM OF ACTIONS RESERPINE It blocks the Mg/ATP dependent
VESICULAR MANO AMINE TRANSPORTER(VMAT)
GUANATHEDINE/BRETYLIUM It inhibits nerve impulse coupled N.A
release from vesicles(bretylium). Displaces N.A from storage vesicles Engages and blocks the N.A reuptake at
axonal membrane.(REUPTAKE 1)
![Page 5: Pharmacology of adrenergic neuron blockers](https://reader036.vdocument.in/reader036/viewer/2022082511/546a71d8af79596c268b4a39/html5/thumbnails/5.jpg)
RESERPINEORGAN/SITE ACTION
CENTRAL NERVOUS YSTEM ↓ dopamine
↓ serotonin
↓ nor adrenaline
CARDIOVASCULAR SYSTEM ↓ cardiac output
↓ vascular resistance
GIT Ultimate increase motility
Ultimate increased secretions
Reproductive system Decrease in libido
Nasal region Turbinate lateral wall size increase
Eye Dilator pupillae are blocked
Metabolism Anti diabetogenic
![Page 6: Pharmacology of adrenergic neuron blockers](https://reader036.vdocument.in/reader036/viewer/2022082511/546a71d8af79596c268b4a39/html5/thumbnails/6.jpg)
THERAPEUTIC ACTION
RESERPINE
Anti-Hypertensi
ve
Anti-emeti
c
Anti-Psychoti
c
![Page 7: Pharmacology of adrenergic neuron blockers](https://reader036.vdocument.in/reader036/viewer/2022082511/546a71d8af79596c268b4a39/html5/thumbnails/7.jpg)
ADVERSE EFFECTS
Organ/site effect
CENTRAL NERVOUS SYSTEM DEPRESSION (suicidal tendency)
NIGHTMARES
EXTRA PYRAMIDAL (PARKINSON) EFFECTS
CARDIOVASCULAR SYSTEM MILD POSTURAL HYPOTENSION
GIT DIARRHOEA
ACIDITY
NASAL REGION NASAL CONGESTION
REPRODUCTIVE SYSTEM DELAYED EJACULATION
![Page 8: Pharmacology of adrenergic neuron blockers](https://reader036.vdocument.in/reader036/viewer/2022082511/546a71d8af79596c268b4a39/html5/thumbnails/8.jpg)
CONTRA INDICATIONS PEPTIC ULCER DEPRESSION
![Page 9: Pharmacology of adrenergic neuron blockers](https://reader036.vdocument.in/reader036/viewer/2022082511/546a71d8af79596c268b4a39/html5/thumbnails/9.jpg)
GUANETHIDINE.
Lowering of BP
Triphasic response
Biphasic response
Monophasic
response
![Page 10: Pharmacology of adrenergic neuron blockers](https://reader036.vdocument.in/reader036/viewer/2022082511/546a71d8af79596c268b4a39/html5/thumbnails/10.jpg)
GUANETHIDINE
ORGAN/SITE ACTION
CENTRAL NEROUS SYSTEM DOESN’T CROSS BBB
RENAL ↓INITIAL BLOOD FLOW, (regulatory action)
GASTRO INTESTINAL TRACT INCREASE MOTILITY(PSNS)
INCREASE SECRETIONS(PSNS)
EYE DECREASE I.O.T
MIOSIS
NASAL REGION INCREASE SIZE OF TURBINATE LATERAL WALLS (INCREASE CORONARY FLOW)
![Page 11: Pharmacology of adrenergic neuron blockers](https://reader036.vdocument.in/reader036/viewer/2022082511/546a71d8af79596c268b4a39/html5/thumbnails/11.jpg)
ADVERSE EFFECTS Postural hypotension Weakness Diarrhoea Delayed or retrograde ejaculation Nasal stuffiness It cause super sensitivity of receptors
leading to regulation of α1 receptors causing intense vasoconstriction (HTN crisis)
Fluid retention (long term use tolerance develops)
Worsening of CCF.
![Page 12: Pharmacology of adrenergic neuron blockers](https://reader036.vdocument.in/reader036/viewer/2022082511/546a71d8af79596c268b4a39/html5/thumbnails/12.jpg)
THERAPEUTIC PURPOSES ANTI HYPERTENSIVE(Last choice
therapy) For management of Pheochromocytoma
![Page 13: Pharmacology of adrenergic neuron blockers](https://reader036.vdocument.in/reader036/viewer/2022082511/546a71d8af79596c268b4a39/html5/thumbnails/13.jpg)
BRETYLIUM ACTIVITY Prolongs duration of ventricular action potential It prolongs the refractory period of ischemic heart
tissue and decreases its excitability(by blocking K+ channels)
Also blocks N.A release. THERAPEUTIC USE Anti- arrhythmic Anti-hypertensive ADVERSE EFFECTS Postural hypotension Bradycardia Nausea/Vomiting
![Page 14: Pharmacology of adrenergic neuron blockers](https://reader036.vdocument.in/reader036/viewer/2022082511/546a71d8af79596c268b4a39/html5/thumbnails/14.jpg)
THANK YOU